BAP C™ For Treating Asherman’s syndrome
Rejuvenating the uterus from scar tissues.
What is Treating Asherman’s syndrome?
Asherman’s syndrome is a condition where the growth of scar tissues takes place along the uterine lining. It reduces the overall receptivity on the uterine area required for conception. Caused due to trauma to the endometrial lining, it eventually triggers the normal wound-healing process. As a result, the wounded areas fuse together to form a scar tissue. In many cases, the front and back walls of the uterus stick to one another. Most commonly, such intrauterine adhesions occur after a Dilation and Curettage (D&C) procedure. Recurrent miscarriage and infertility could also be symptoms.
Dilation and Curettage is a procedure used by the doctors to scrape the endometrium, which is the inner lining of the uterus, after an abortion or infection in the uterine lining. Pregnancy-related D&Cs have been shown to account for 90% of Asherman’s Syndrome cases.
Misprostol is a synthetic medication that has shown great success as an alternative for D&C procedures. Initially developed for treating ulcers, studies have conclusively deemed misprostol to be a huge impact drug for gynaecology problems, especially bleeding. The process relatively has very less negative impact by the virtue of invasiveness, cost and damage, when pitted against D&C.
Most patients with Asherman’s Syndrome have reduced periods, eventually leading up to lack of menstrual cycle. Among those who have no periods, most of them feel pain at the time their period would normally arrive each month. This pain may indicate that menstrual blood is unable to exit the uterus because of blockages by adhesions. Recurrent miscarriage is also a key symptom to Asherman’s syndrome.
Why BAP C™ For Treating
Ease of Treatment
Asherman’s Syndrome is usually treated by operative hysteroscopy, a procedure well-versed by only few experienced surgeons in the country. BAP C™ assures that both success rate and ease of treatment come together in place of invasive surgeries. helps stimulate them and increase the chances of IVF success. BAP C™ is transfused into endometrium to induce regeneration of the same, which is reflected by restoration of menstruation in the patient. It also removes the scars tissues by tissue regeneration over the undesirable layers of adhesion.
BAP C™ is a path-breaking regenerative medicine, which is extremely safe since it is drawn from the patient’s own blood. The growth potion is prepared from concentrated platelets derived from fresh peripheral blood that is collected from a peripheral vein. These growth factors trigger the appropriate ovarian centres to promote the regeneration of eggs in the ovaries. Also, BAP C™ has no side effects, since the process only stimulates the natural repair mechanisms of the human body.
Seamless Integration With IVF
BAP C™ protocol seamlessly fits in your IVF procedure and ensures no glitch in your schedule. BAP C™ is ready to use with zero downtime to doctors. Focus on providing stellar care to your patients and leave the rest to BAP C™.
How It Works
Peripheral Blood Aspiration
The entire BAP C™ protocol is autologous and starts with phlebotomist extracting fresh peripheral blood. BAP C™ is prepared from fresh peripheral blood which is aspirated from a peripheral vein, stored in anticoagulant and processed to increase platelets by separating various components in blood.
Growth Factors Activation
The growth concentrate is stored in an anticoagulant and processed to separate various components of blood. The derived platelet fraction is concentrated further, which triggers their activation. The activated platelets turn the cytokines and growth factors into bioactive elements that start acting up in just 10 minutes following transfusion. These growth factors treat infertility very efficiently, thanks to their inventory of regulating cell migration, attachment, proliferation and differentiation, and promoting extracellular matrix accumulation.
BAP C™ Transfusion
The activated BAP C™ will be infused into each ovary using a transvaginal ultrasound technique. Once transfused into the ovaries,BAP C™ starts regulating the hormones to improve the reception of ovarian sites. In the next stage, the intrinsic growth factors are activated by our wonder potion. The stimulated stem cells are proven to develop and transform into eggs. The role of stem cells in ovarian regeneration has also been attested by Harvard researchers, and our benchmark BAP C™ C potion does exactly that, by activating stem cells with Platelet Derived Growth Factors (PGDF).
Miscarriage patient with pronounced anaemic condition treated for Endometrial paucity reported success in 36 hours.
42 year old with repeated IVF failures treated for Endometrial thickness. Results seen in 72 hours.
Patient with 2 MM thickness, reported a growth of 6.9 MM within 48 hours and implantation carried out leading to succesful conception.